The global dual specificity tyrosine phosphorylation regulated kinase 1A market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Dual-specificity tyrosine phosphorylation-regulated kinase 1A or DYRK1A is a eukaryotic serine-threonine protein kinase that belongs to the CMGC group and contributes to the development of several human malignancies and cognitive deficits that are observed in down syndrome and Alzheimer’s disease. The major factor accelerating the growth of the market is the increasing prevalence of Alzheimer’s disease across the globe.
To Request a Sample of our Report on Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market: https://www.omrglobal.com/request-sample/dual-specificity-tyrosine-phosphorylation-regulated-kinase-1a-market
According to the Alzheimer’s Association, more than 6 million Americans of all ages have Alzheimer’s. Additionally, in 2021, an estimated 6.2 million Americans age 65 and older are living with Alzheimer’s dementia out of which 72% are aged 75 or older. Furthermore, as per the same source, one in nine people age 65 and older or 11.3% has Alzheimer’s dementia. Moreover, almost two-thirds of Americans with Alzheimer’s are women. Apart from this, the number of people aged 65 and older with Alzheimer’s dementia is estimated to grow to 12.7 million by 2050. Hence, the increasing Alzheimer’s disease is resulting increased prevalence of cognitive deficits and human malignancies which in turn is driving the growth of the market.
Some major players operating in the market include Pharmasum Therapeutics AS, Carna Biosciences Inc., and NeuroNascent Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in September 2021, Brickell Biotech, Inc. announced that it has entered into a definitive agreement with Voronoi Inc. The agreement was aimed to grant Brickell exclusive, global rights to research, develop and commercialize novel therapeutics generated from a proprietary DYRK1A inhibitor platform.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape– Pharmasum Therapeutics AS, Carna Biosciences Inc., and NeuroNascent Inc., among others.
(Get 15% Discount on Buying this Report)
A full Report of Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market is Available @ https://www.omrglobal.com/industry-reports/dual-specificity-tyrosine-phosphorylation-regulated-kinase-1a-market
Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Report by Segment
By Type
- PST-900
- NNI-351
- FX-9847
- Others
By Application
- Colon Cancer
- Down Syndrome
- Lung Cancer
- Pancreatic Cancer
- Others
Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
